Advertisement
Erratum| Volume 95, ISSUE 7, P627, July 2001

Changes in asthma drug therapy costs for patients receiving chronic montelukast therapy in the U.K.

Volume 95, pp. 83-89
Open ArchiveDOI:https://doi.org/10.1053/rmed.2001.1136
Changes in asthma drug therapy costs for patients receiving chronic montelukast therapy in the U.K.
Previous ArticleThe body weight–walking distance product as related to lung function, anaerobic threshold and peakV̇O2in COPD patients
Next ArticleCalendar
      This paper is only available as a PDF. To read, Please Download here.

      Article info

      Identification

      DOI: https://doi.org/10.1053/rmed.2001.1136

      Copyright

      © 2001 Harcourt Publishers Ltd. Published by Elsevier Inc.

      User license

      Elsevier user license |
      How you can reuse Information Icon
      Elsevier user license

      Permitted

      For non-commercial purposes:

      • Read, print & download
      • Text & data mine
      • Translate the article

      Not Permitted

      • Reuse portions or extracts from the article in other works
      • Redistribute or republish the final article
      • Sell or re-use for commercial purposes

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX